Viral proteins are encoded by the viral genome and include both structural and non-structural proteins. Structural and functional studies of viral proteins pave the way for understanding viral infection mechanisms and developing targeted drugs and vaccines. CD ComputaBio relies on the world's leading computational biology platform and integrates multi-dimensional technologies such as machine learning, deep learning, and molecular dynamics simulation to provide scientific research institutions and pharmaceutical companies with a full-process solution for high-precision viral protein modeling.
Viral protein modeling is important for understanding viral biology and developing antiviral therapies. It involves computational prediction of the three-dimensional (3D) structure and property analysis of viral proteins, which is crucial for understanding viral mechanisms, developing antiviral drugs, and designing vaccines. Viral protein modeling helps to quickly identify active sites and allosteric regulatory regions of key viral replication proteins (such as SARS-CoV-2 main protease and HIV reverse transcriptase), accelerating inhibitor design. Viral protein modeling helps to analysis of virus-host interaction mechanisms. For example, by modeling the binding interface between the spike protein and ACE2, researchers can effectively predict the immune escape potential of mutant strains, such as Omicron, and generate valuable insights for the development of broadly protective vaccines.
Fig 1. Viral protein family (VPF) function prediction using protein language models (PLMs) uncovers novel biology. (Flamholz Z N, et al., 2024)
Low-Resolution Modeling
Using low-resolution modeling technology, the prediction coverage rate is still maintained at 75% at medium resolution (4-6Å), which greatly expands the range of available data.
01Multi-target Cross-Interference Analysis
Apply the HOMOLOBIND algorithm to construct a virus-host interaction network, predict the selectivity differences of drugs for multi-protein targets, and avoid off-target effects.
02CD ComputaBio offers customized viral protein modeling services, from structure prediction to functional analysis. Leveraging integrated databases (PDB, viral protein, and proprietary) and AI-powered models, CD ComputaBio support accurate modeling of post-translational modifications such as glycosylation and phosphorylation, covering more than 90% of known viral protein families.
DNA Virus Proteins Modeling |
|
|
|
|
|
|
|
|
|
|
|
RNA Virus Proteins Modeling |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prion Proteins Modeling |
|
|
|
GROMACS
High-performance molecular dynamics simulation software for conformational rearrangement of viral capsid proteins and simulation of membrane fusion processes (such as pH-dependent conformational changes of Ebola virus GP protein).
AutoDock Vina
It is used to screen inhibitors targeting viral proteins (such as anti-HIV integrase compound library screening).
HADDOCK
Flexible docking based on experimental constraints to analyze the interface interactions between viral proteins and host receptors (such as the binding interface between HPV L1 protein and neutralizing antibodies).
Cytoscape
Visualize the regulatory nodes of viral proteins in host signaling pathways (such as the interaction network between Epstein-Barr virus LMP1 protein and NF-κB pathway).
CD ComputaBio offers a comprehensive suite of services to model viral proteins with high accuracy. Our team of experts, state-of-the-art tools, and customized solutions ensure that we deliver high-quality results to our clients. By choosing CD ComputaBio, you can accelerate your drug discovery process, reduce costs, and improve the success rate of your projects. For inquiries or to discuss your specific project requirements, please contact us today.
Reference: